Eculizumab hepatotoxicity in pediatric aHUS

Eculizumab is a humanized anti-C5 antibody approved for the treatment of atypical hemolytic uremic syndrome (aHUS). Its use is increasing in children following reports of its safety and efficacy.

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Hayes, Wesley (VerfasserIn) , Tschumi, Sibylle (VerfasserIn) , Ling, Simon C. (VerfasserIn) , Feber, Janusz (VerfasserIn) , Kirschfink, Michael (VerfasserIn) , Licht, Christoph (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 2015
In: Pediatric nephrology
Year: 2014, Jahrgang: 30, Heft: 5, Pages: 775-781
ISSN:1432-198X
DOI:10.1007/s00467-014-2990-5
Online-Zugang:Verlag, Volltext: https://doi.org/10.1007/s00467-014-2990-5
Volltext
Verfasserangaben:Wesley Hayes, Sibylle Tschumi, Simon C. Ling, Janusz Feber, Michael Kirschfink, Christoph Licht

MARC

LEADER 00000caa a2200000 c 4500
001 1724939963
003 DE-627
005 20220818151545.0
007 cr uuu---uuuuu
008 200716r20152014xx |||||o 00| ||eng c
024 7 |a 10.1007/s00467-014-2990-5  |2 doi 
035 |a (DE-627)1724939963 
035 |a (DE-599)KXP1724939963 
035 |a (OCoLC)1341345364 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Hayes, Wesley  |e VerfasserIn  |0 (DE-588)1213910579  |0 (DE-627)1724939343  |4 aut 
245 1 0 |a Eculizumab hepatotoxicity in pediatric aHUS  |c Wesley Hayes, Sibylle Tschumi, Simon C. Ling, Janusz Feber, Michael Kirschfink, Christoph Licht 
264 1 |c 2015 
300 |a 7 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Published online: 22 November 2014 
500 |a Gesehen am 16.07.2020 
520 |a Eculizumab is a humanized anti-C5 antibody approved for the treatment of atypical hemolytic uremic syndrome (aHUS). Its use is increasing in children following reports of its safety and efficacy. 
534 |c 2014 
700 1 |a Tschumi, Sibylle  |e VerfasserIn  |4 aut 
700 1 |a Ling, Simon C.  |e VerfasserIn  |4 aut 
700 1 |a Feber, Janusz  |e VerfasserIn  |4 aut 
700 1 |a Kirschfink, Michael  |e VerfasserIn  |0 (DE-588)120927152  |0 (DE-627)080974457  |0 (DE-576)292452411  |4 aut 
700 1 |a Licht, Christoph  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t Pediatric nephrology  |d Berlin : Springer, 1987  |g 30(2015), 5, Seite 775-781  |h Online-Ressource  |w (DE-627)254638872  |w (DE-600)1463004-7  |w (DE-576)074531689  |x 1432-198X  |7 nnas  |a Eculizumab hepatotoxicity in pediatric aHUS 
773 1 8 |g volume:30  |g year:2015  |g number:5  |g pages:775-781  |g extent:7  |a Eculizumab hepatotoxicity in pediatric aHUS 
856 4 0 |u https://doi.org/10.1007/s00467-014-2990-5  |x Verlag  |x Resolving-System  |3 Volltext 
951 |a AR 
992 |a 20200716 
993 |a Article 
994 |a 2015 
998 |g 120927152  |a Kirschfink, Michael  |m 120927152:Kirschfink, Michael  |d 910000  |d 911600  |e 910000PK120927152  |e 911600PK120927152  |k 0/910000/  |k 1/910000/911600/  |p 5 
999 |a KXP-PPN1724939963  |e 3724739419 
BIB |a Y 
SER |a journal 
JSO |a {"type":{"media":"Online-Ressource","bibl":"article-journal"},"note":["Published online: 22 November 2014","Gesehen am 16.07.2020"],"language":["eng"],"recId":"1724939963","title":[{"title":"Eculizumab hepatotoxicity in pediatric aHUS","title_sort":"Eculizumab hepatotoxicity in pediatric aHUS"}],"person":[{"role":"aut","roleDisplay":"VerfasserIn","display":"Hayes, Wesley","given":"Wesley","family":"Hayes"},{"role":"aut","display":"Tschumi, Sibylle","roleDisplay":"VerfasserIn","given":"Sibylle","family":"Tschumi"},{"role":"aut","roleDisplay":"VerfasserIn","display":"Ling, Simon C.","given":"Simon C.","family":"Ling"},{"given":"Janusz","family":"Feber","role":"aut","roleDisplay":"VerfasserIn","display":"Feber, Janusz"},{"role":"aut","roleDisplay":"VerfasserIn","display":"Kirschfink, Michael","given":"Michael","family":"Kirschfink"},{"role":"aut","display":"Licht, Christoph","roleDisplay":"VerfasserIn","given":"Christoph","family":"Licht"}],"physDesc":[{"extent":"7 S."}],"relHost":[{"part":{"year":"2015","issue":"5","pages":"775-781","volume":"30","text":"30(2015), 5, Seite 775-781","extent":"7"},"pubHistory":["1.1987 -"],"recId":"254638872","language":["eng"],"type":{"media":"Online-Ressource","bibl":"periodical"},"disp":"Eculizumab hepatotoxicity in pediatric aHUSPediatric nephrology","note":["Gesehen am 06.12.05"],"title":[{"subtitle":"journal of the International Pediatric Nephrology Association","title":"Pediatric nephrology","title_sort":"Pediatric nephrology"}],"physDesc":[{"extent":"Online-Ressource"}],"id":{"zdb":["1463004-7"],"eki":["254638872"],"issn":["1432-198X"]},"origin":[{"dateIssuedDisp":"1987-","publisher":"Springer ; Springer","dateIssuedKey":"1987","publisherPlace":"Berlin ; Heidelberg ; Berlin ; Heidelberg ; New York, NY"}]}],"origin":[{"dateIssuedDisp":"2015","dateIssuedKey":"2015"}],"id":{"eki":["1724939963"],"doi":["10.1007/s00467-014-2990-5"]},"name":{"displayForm":["Wesley Hayes, Sibylle Tschumi, Simon C. Ling, Janusz Feber, Michael Kirschfink, Christoph Licht"]}} 
SRT |a HAYESWESLEECULIZUMAB2015